Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement

Ned Calonge; Diana B. Petitti; Thomas G. DeWitt; Leon Gordis; Kimberly D. Gregory; Russell Harris; George Isham; Michael L. LeFevre; Carol Loveland-Cherry; Lucy N. Marion; Virginia A. Moyer; Judith K. Ockene; George F. Sawaya; Albert L. Siu; Steven M. Teutsch; Barbara P. Yawn

doi:10.7326/0003-4819-148-10-200805200-00008

Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Leon Gordis, Kimberly D. Gregory, Russell Harris, George Isham, Michael L. LeFevre, Carol Loveland-Cherry, Lucy N. Marion, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Albert L. Siu, Steven M. Teutsch, Barbara P. Yawn

Biobehavioral Nursing

Research output: Contribution to journal › Review article › peer-review

88 Scopus citations

Abstract

Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).

Original language	English (US)
Pages (from-to)	759-765
Number of pages	7
Journal	Annals of internal medicine
Volume	148
Issue number	10
DOIs	https://doi.org/10.7326/0003-4819-148-10-200805200-00008
State	Published - May 20 2008

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-148-10-200805200-00008

Cite this

Calonge, N., Petitti, D. B., DeWitt, T. G., Gordis, L., Gregory, K. D., Harris, R., Isham, G., LeFevre, M. L., Loveland-Cherry, C., Marion, L. N., Moyer, V. A., Ockene, J. K., Sawaya, G. F., Siu, A. L., Teutsch, S. M., & Yawn, B. P. (2008). Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement. Annals of internal medicine, 148(10), 759-765. https://doi.org/10.7326/0003-4819-148-10-200805200-00008

Calonge, N, Petitti, DB, DeWitt, TG, Gordis, L, Gregory, KD, Harris, R, Isham, G, LeFevre, ML, Loveland-Cherry, C, Marion, LN, Moyer, VA, Ockene, JK, Sawaya, GF, Siu, AL, Teutsch, SM & Yawn, BP 2008, 'Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement', Annals of internal medicine, vol. 148, no. 10, pp. 759-765. https://doi.org/10.7326/0003-4819-148-10-200805200-00008

@article{1b749567e7b94579b71a9bac9bd60110,

title = "Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement",

abstract = "Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).",

author = "Ned Calonge and Petitti, {Diana B.} and DeWitt, {Thomas G.} and Leon Gordis and Gregory, {Kimberly D.} and Russell Harris and George Isham and LeFevre, {Michael L.} and Carol Loveland-Cherry and Marion, {Lucy N.} and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Siu, {Albert L.} and Teutsch, {Steven M.} and Yawn, {Barbara P.}",

year = "2008",

month = may,

day = "20",

doi = "10.7326/0003-4819-148-10-200805200-00008",

language = "English (US)",

volume = "148",

pages = "759--765",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "10",

}

TY - JOUR

T1 - Screening for gestational diabetes mellitus

T2 - U.S. preventive services task force recommendation statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - DeWitt, Thomas G.

AU - Gordis, Leon

AU - Gregory, Kimberly D.

AU - Harris, Russell

AU - Isham, George

AU - LeFevre, Michael L.

AU - Loveland-Cherry, Carol

AU - Marion, Lucy N.

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Siu, Albert L.

AU - Teutsch, Steven M.

AU - Yawn, Barbara P.

PY - 2008/5/20

Y1 - 2008/5/20

N2 - Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).

AB - Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).

UR - http://www.scopus.com/inward/record.url?scp=44149095548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44149095548&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-148-10-200805200-00008

DO - 10.7326/0003-4819-148-10-200805200-00008

M3 - Review article

C2 - 18490688

AN - SCOPUS:44149095548

VL - 148

SP - 759

EP - 765

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 10

ER -

Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this